Celda Pharmaceuticals Private Limited
About Celda Pharmaceuticals Private Limited
Data last updated:
Celda Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2021PTC154442.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deva Narendra and Battina Suresh Babu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.2 Naganathapura Gramatana Naganathapura Revenue Layout, Bangalore, Karnataka, India – 560100.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.06 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹43,108 (net margin -2.5%) and EBITDA of -₹43,108 (EBITDA margin -2.5%).
Company details
Contact details
Celda Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo.2 Naganathapura Gramatana Naganathapura Revenue Layout, Bangalore, Karnataka, India – 560100
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Celda Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Celda Pharmaceuticals Private Limited, buy the company report.
Financials of Celda Pharmaceuticals Private Limited
FY 2025 filings availableCelda Pharmaceuticals Private Limited reported revenue of ₹17.06 Lakh (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 34% in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹43,108 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹43,108 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -2.5% | |||
| Net Profit Margin | -2.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Celda Pharmaceuticals Private Limited, buy the company report.
Board of directors of Celda Pharmaceuticals Private Limited
Celda Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deva Narendra | Director | 16 Nov 2021 | 4 Years 11 Months | Current |
| Battina Suresh Babu | Director | 16 Nov 2021 | 4 Years 11 Months | Current |
| Nagaraja Simhadri Also directs: Sun Vision Remedies Private Limited | Director | 31 Dec 2024 | 1 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Celda Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celda Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Celda Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Celda Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Nagaraja Simhadri was appointed as Director on 31 Dec 2024.
Frequently asked questions
Celda Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 16 November 2021 (5+ years old) and is registered under CIN U51909KA2021PTC154442.
Celda Pharmaceuticals has 3 current directors:
- Deva Narendra - Director
- Battina Suresh Babu - Director
- Nagaraja Simhadri - Director
The latest financial statements of Celda Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Celda Pharmaceuticals is U51909KA2021PTC154442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celda Pharmaceuticals was incorporated on 16 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Nagaraja Simhadri was appointed as Director on 31 Dec 2024. Battina Suresh Babu was appointed as Director on 16 Nov 2021. Deva Narendra was appointed as Director on 16 Nov 2021.
The registered office of Celda Pharmaceuticals is at No.2 Naganathapura Gramatana Naganathapura Revenue Layout, Bangalore, Karnataka, India – 560100.
Celda Pharmaceuticals operates in the trading industry, in the specialty segment.
Celda Pharmaceuticals can be reached at its registered office: No.2 Naganathapura Gramatana Naganathapura Revenue Layout, Bangalore, Karnataka, India – 560100.
Celda Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.